IS8660A - Glycoside pharmaceutical composition - Google Patents

Glycoside pharmaceutical composition

Info

Publication number
IS8660A
IS8660A IS8660A IS8660A IS8660A IS 8660 A IS8660 A IS 8660A IS 8660 A IS8660 A IS 8660A IS 8660 A IS8660 A IS 8660A IS 8660 A IS8660 A IS 8660A
Authority
IS
Iceland
Prior art keywords
pharmaceutical composition
glycoside
glycoside pharmaceutical
composition
pharmaceutical
Prior art date
Application number
IS8660A
Other languages
Icelandic (is)
Inventor
Jens Bjarnason Guðmundur
Original Assignee
Actavis Group Ptc Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Ptc Ehf. filed Critical Actavis Group Ptc Ehf.
Priority to IS8660A priority Critical patent/IS8660A/en
Priority to PCT/IS2008/000015 priority patent/WO2009004654A2/en
Publication of IS8660A publication Critical patent/IS8660A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8660A 2007-07-02 2007-07-02 Glycoside pharmaceutical composition IS8660A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IS8660A IS8660A (en) 2007-07-02 2007-07-02 Glycoside pharmaceutical composition
PCT/IS2008/000015 WO2009004654A2 (en) 2007-07-02 2008-07-02 Modified release dosage form of sulfonylurea compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS8660A IS8660A (en) 2007-07-02 2007-07-02 Glycoside pharmaceutical composition

Publications (1)

Publication Number Publication Date
IS8660A true IS8660A (en) 2009-01-03

Family

ID=40042546

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8660A IS8660A (en) 2007-07-02 2007-07-02 Glycoside pharmaceutical composition

Country Status (2)

Country Link
IS (1) IS8660A (en)
WO (1) WO2009004654A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200704897A1 (en) * 2007-07-13 2009-02-23 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Glyclazide formulations providing extended release @

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266542A3 (en) * 1998-10-01 2013-07-31 Elan Pharma International Limited Controlled release nanoparticulate compositions
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
CN1874774B (en) * 2003-10-31 2011-04-13 武田药品工业株式会社 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
WO2006030303A1 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Oral extended release dosage form comprising a high dose biguanide and a low dose sulfonylurea
WO2006123213A1 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Modified release formulations of gliclazide
EP1938842A4 (en) * 2005-09-01 2013-01-09 Eisai R&D Man Co Ltd Method for preparation of pharmaceutical composition having improved disintegradability

Also Published As

Publication number Publication date
WO2009004654A2 (en) 2009-01-08
WO2009004654A3 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
LTC2140867I2 (en) Pharmaceutical composition
LTPA2018014I1 (en) Pharmaceutical Composition 514
BRPI0721651A2 (en) PHARMACEUTICAL COMPOSITION
BRPI0715712A2 (en) PHARMACEUTICAL COMPOSITION
DK3492069T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE
BRPI0719393A2 (en) Pharmaceutical Composition
DK2120884T3 (en) Pharmaceutical composition
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0813775A2 (en) COMPOSITION
BRPI0716445A2 (en) pharmaceutical composition
BRPI0720234A2 (en) PHARMACEUTICAL COMPOSITION
ATE528048T1 (en) ANTISWEATING/DEODODORIZING COMPOSITION
DK2966175T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CORTEXOLON-17-ALPHA-PROPIONATE
DK2285413T3 (en) Pharmaceutical composition
BRPI0810557A2 (en) composition
PT2209464E (en) ANTIMALARIC PHARMACEUTICAL COMPOSITION
BRPI0811274A2 (en) COMPOSITION
EP2236149A4 (en) MEDICINAL COMPOSITION
BRPI0921313A2 (en) pharmaceutical composition
BRPI0820198A2 (en) pharmaceutical compositions
BRPI0811002A2 (en) BIOFERTILIZING COMPOSITION
BRPI0820960A2 (en) composition
BRPI0912171A2 (en) pharmaceutical composition
DK2271321T3 (en) Pharmaceutical Composition 271
EP2119430A4 (en) PERLED COMPOSITION